Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń

Warszawa, Poland
Specialized hospital in Warsaw
Williama Heerleina Lindleya 4, 02-005 Warszawa

About Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń


During the past decade, Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis
2016-10-01
2017-08-01
Completed
74
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
2018-03-07
2019-02-05
Completed
385
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
2018-07-13
2020-09-09
Terminated
484
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
2018-05-01
2018-10-08
Completed
116
A Study Evaluating the Long-term Safety of VX-445 Combination Therapy
2019-08-09
2022-12-14
Completed
458
A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
2019-08-28
2020-06-12
Completed
271
Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy
2019-12-05
2022-12-16
Completed
251
A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)
2021-01-18
2022-07-14
Completed
69

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" #1 sponsor was "Abbott" with 2 trials, followed by "Sangart" with 2 trials sponsored, "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored, "Cell Genesys" with 1 trials sponsored and "Medical University of Lublin" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" #1 collaborator was "Allergan" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń


According to Clinical.Site data, the most researched conditions in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" are "Bladder Cancer" (2 trials), "Hypotension" (2 trials), "Ischemia" (2 trials), "Prostate Cancer" (2 trials) and "Cesarean Section" (1 trials). Many other conditions were trialed in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" in a lesser frequency.

Clinical Trials Intervention Types at Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń


Most popular intervention types in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" are "Drug" (8 trials), "Biological" (2 trials), "Procedure" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Apaziquone" (2 trials), "Atrasentan" (2 trials), "Hemospan (MP4OX)" (2 trials) and "Voluven (HES 130/0.4)" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń


The vast majority of trials in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń" are 5 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Clinical Trials Status at Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń


Currently, there are NaN active trials in "Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status